Claudio Zamperini

Via Vittorio Alfieri 31
Castelnuovo Berardenga, 53019, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Blocking Host Factors IAP and DDX3 Activates HIV-1 Transcription and Increases Apoptosis Sensitivity of HIV-1 Infected Cells.

Blocking Host Factors IAP and DDX3 Activates HIV-1 Transcription and Increases Apoptosis Sensitivity of HIV-1 Infected Cells.

Journal: Pathogens (Basel, Switzerland)

Published: February 16, 2026

Noncanonical-NF-κB activation and DDX3 inhibition reduces the HIV-1 reservoir by elimination of latently infected cells ex-vivo.

Noncanonical-NF-κB activation and DDX3 inhibition reduces the HIV-1 reservoir by elimination of latently infected cells ex-vivo.

Journal: Microbiology spectrum

Published: December 05, 2023

The Pyrazolo[3,4-d]Pyrimidine Derivative Si306 Encapsulated into Anti-GD2-Immunoliposomes as Therapeutic Treatment of Neuroblastoma.

The Pyrazolo[3,4-d]Pyrimidine Derivative Si306 Encapsulated into Anti-GD2-Immunoliposomes as Therapeutic Treatment of Neuroblastoma.

Journal: Biomedicines

Published: February 14, 2022

Targeting DDX3X Helicase Activity with BA103 Shows Promising Therapeutic Effects in Preclinical Glioblastoma Models.

Targeting DDX3X Helicase Activity with BA103 Shows Promising Therapeutic Effects in Preclinical Glioblastoma Models.

Journal: Cancers

Published: September 27, 2021

Si113-prodrugs selectively activated by plasmin against hepatocellular and ovarian carcinoma.

Si113-prodrugs selectively activated by plasmin against hepatocellular and ovarian carcinoma.

Journal: European journal of medicinal chemistry

Published: March 18, 2021

DDX3X inhibitors, an effective way to overcome HIV-1 resistance targeting host proteins.

DDX3X inhibitors, an effective way to overcome HIV-1 resistance targeting host proteins.

Journal: European journal of medicinal chemistry

Published: January 29, 2020

Synthesis and Antiproliferative Activity of Nitric Oxide-Donor Largazole Prodrugs.

Synthesis and Antiproliferative Activity of Nitric Oxide-Donor Largazole Prodrugs.

Journal: ACS medicinal chemistry letters

Published: December 23, 2019

Multitarget CFTR Modulators Endowed with Multiple Beneficial Side Effects for Cystic Fibrosis Patients: Toward a Simplified Therapeutic Approach †.

Multitarget CFTR Modulators Endowed with Multiple Beneficial Side Effects for Cystic Fibrosis Patients: Toward a Simplified Therapeutic Approach †.

Journal: Journal of medicinal chemistry

Published: November 16, 2019

Synthesis and Antiviral Activity of Novel 1,3,4-Thiadiazole Inhibitors of DDX3X.

Synthesis and Antiviral Activity of Novel 1,3,4-Thiadiazole Inhibitors of DDX3X.

Journal: Molecules (Basel, Switzerland)

Published: September 02, 2019

In vitro characterization, ADME analysis, and histological and toxicological evaluation of BM1, a macrocyclic amidinourea active against azole-resistant Candida strains.

In vitro characterization, ADME analysis, and histological and toxicological evaluation of BM1, a macrocyclic amidinourea active against azole-resistant Candida strains.

Journal: International journal of antimicrobial agents

Published: July 16, 2019

A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor.

A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor.

Journal: Cancers

Published: May 16, 2019

DDX3X Helicase Inhibitors as a New Strategy To Fight the West Nile Virus Infection.

DDX3X Helicase Inhibitors as a New Strategy To Fight the West Nile Virus Infection.

Journal: Journal of medicinal chemistry

Published: February 06, 2019

Showing 1-12 of 40

Last Updated: 09/26/2026